Reversible selective beta(2)-adrenoceptor agonist-induced myopathy.
Hellier
J-P
JP
Baudrimont
M
M
Dussaule
J C
JC
Berenbaum
F
F
D000281:Administration, Intranasal; D000284:Administration, Oral; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000009:adverse effects*; D000368:Aged; D000420:Albuterol / Q000008:administration & dosage / Q000009:adverse effects*; D001249:Asthma / Q000188:drug therapy*; D001707:Biopsy, Needle; D004576:Electromyography; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D009135:Muscular Diseases / Q000139:chemically induced* / Q000175:diagnosis*; D018570:Risk Assessment
D000319:Adrenergic beta-Antagonists; D000420:Albuterol